"Revolutionary Single-Dose Gene Therapy Transforms Lives of Hereditary Angioedema Patients"

A single-dose gene therapy using CRISPR has shown promising results in treating hereditary angioedema, a rare genetic disorder causing painful and potentially fatal swelling. Patients in a human trial reported dramatic improvements in their health and quality of life, with some describing it as a "medical magic wand." The treatment corrects the C1 kallikrein gene and has the potential to transform the lives of those affected by the condition, although it comes with a high cost.